Cassava Sciences Shares Lower Premarket on $40M Penalty to Settle Doctored Data Claims
Cassava Sciences shares fell in premarket trading Friday after regulators said the company, along with two former executives, will pay more than $40 million to settle charges related to misleading statements made about the clinical trial of its Alzheimer's disease treatment.
Discover how exercise, a healthy diet, and socialization can help combat Alzheimer's disease. Learn more about the importance ...
An investigation on tiny worms has discovered that a common nutrient may protect against Alzheimer's disease and early death.
Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made m | Cassava Sciences has ...
Legal counsel for the 83-year-old CEO of Herring Networks seek to block his deposition in Dominion Voting's ...
After nabbing a new FDA license for Rexulti in Alzheimer’s agitation last year, the drug’s marketing duo Lundbeck and Otsuka ...
A critical review of the limitations posed by current preclinical animal models of Alzheimer's disease and of the oversimplistic assumptions proposed by the amyloid cascade hypothesis (ACH).
New research says that light pollution and Alzheimer's may actually have a connection. Here's what you need to know.
Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...
Hundreds of walkers will lace up their shoes this weekend to raise money to battle Alzheimer’s and Huntington’s Disease.
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...
Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...
About 6.7 million Americans age 65 and older are living with Alzheimer's dementia, according to the NIH. By 2060, that could hit 13.8 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback